Amid the rising global outbreak of Mpox, two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine ...

2 Modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine (trade names Imvamune, Jynneos, and Imvanex) is a third ...

As of now, when it comes to protection against prevalent diseases, Dr Gagandeep Kang, a renowned virologist, points that our ...

Two recent studies reveal that the efficacy of Bavarian Nordic's Mpox vaccine significantly declines within 6-12 months ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in ...

Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to ...

The Vaccine Alliance, Gavi, and Bavarian Nordic announced an Advance Purchase Agreement on Wednesday to secure 500,000 doses ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox ...